 early weeks following these events. A meta-analysis of
eight randomized clinical trials including 20,728 patients
demonstrated that short-term (<3 months) dual antiplatelet therapy with aspirin and clopidogrel compared with
aspirin alone signiï¬cantly decreased risk of recurrent stroke
but it did not increase risk of hemorrhagic complications.
Relative to monotherapy with aspirin, dual therapy with
aspirin and clopidogrel reduced risk